![1]()
News
Choosing Wisely campaign targets waste and overuse in hospital pediatrics
September 8, 2021
Multiple medical societies collaborated to develop guidelines for high-value care with less unnecessary testing and hospitalization.
![1]()
News
United States reaches 5 million cases of child COVID
September 8, 2021
New cases and hospitalizations reach new highs while vaccinations continue to drop in 12- to 15-year-olds.
![1]()
News
COVID-19 continues to complicate children’s mental health care
September 8, 2021
One pediatric hospital’s strategies for managing medical and mental health in the wake of the ongoing pandemic.
![1]()
News
Anakinra improved survival in hospitalized COVID-19 patients
September 7, 2021
Phase 3 randomized trial showed improved survival and shorter hospital stay in COVID-19 patients who were given anakinra, compared with those given a placebo.
News
Health care–associated infections spiked in 2020 in U.S. hospitals
September 7, 2021
This is the first increase in health care–associated infections since 2015.
News
Beta-blocker reduces lung inflammation in critical COVID-19
September 7, 2021
Metoprolol administration also resulted in better oxygenation and fewer days on intensive mechanical ventilation and in the ICU, compared with no treatment.
News
‘Lopioid protocol’ – low-dose opioids – proposed for fracture surgery
September 3, 2021
“Managing narcotics postoperatively can be challenging due to the fact that many people come into these fractures with a history of narcotic use.”
News
WHO tracking new COVID-19 variant called Mu
September 2, 2021
The World Health Organization is tracking a new COVID-19 variant called Mu, which could be able to evade the immunity provided by the vaccines and prior infections.The variant, also kn...
![1]()
News
High prevalence of Fall Risk–Increasing Drugs in older adults after falls
September 2, 2021
Are we reducing use of Fall Risk–Increasing Drugs (FRIDs) after a fall, and if so, does it alone reduce fall risk?
News
Pfizer starts dosing patients in oral COVID-19 drug trial
September 2, 2021
Pfizer’s mid-to-late-stage trial in 1,140 participants would study the therapy PF-07321332 in combination with a low dose of ritonavir.
